Viewing Study NCT06680206

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:59 AM
Ignite Modification Date: 2026-02-26 @ 4:19 PM
Study NCT ID: NCT06680206
Status: COMPLETED
Last Update Posted: 2024-12-31
First Post: 2024-10-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellness Survey
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Migraine View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Rimegepant View
None Triptans View
None Acute treatment of migraine View
None Survey View
None Cross-sectional design View
None National Health and Wellness Survey (NHWS) View
None Patient-reported outcomes View
None Treatment satisfaction View